HQL

abrdn Life Sciences Investors
HQL

Overview Fund Activity

48 hedge funds and large institutions have $56.7M invested in abrdn Life Sciences Investors in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 5 closing their positions.

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
19
Reduced
12
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DA
1
Doliver Advisors
Texas
$1.09M
2
Morgan Stanley
2
Morgan Stanley
New York
$15.2M
3
LTFS
3
Ladenburg Thalmann Financial Services
Florida
$1.1M
4
Cambridge Investment Research Advisors
4
Cambridge Investment Research Advisors
Iowa
$671K
5
Citigroup
5
Citigroup
New York
$748K

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$1.75M
2
Baird Financial Group
2
Baird Financial Group
Wisconsin
$0
3
LPL Financial
3
LPL Financial
California
$1.62M
4
CL
4
CSS LLC
Illinois
$0
5
AAM
5
Advisors Asset Management
Colorado
$4.83M
Name Market Value Shares Shares
Change 		Shares
Change %
GAM
51
Gemmer Asset Management
California
$0 16 – –
Deutsche Bank
52
Deutsche Bank
Germany
$0 2 – –
TWA
53
TCI Wealth Advisors
Arizona
$0 13 +1 +8%
1 2
3